- Home
- CRGX vs BSII Comparison
CRGX vs BSII Comparison
Compare CRGX & BSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- BSII
- Stock Information
- Founded
- CRGX 2021
- BSII 2024
- Country
- CRGX United States
- BSII Hong Kong
- Employees
- CRGX N/A
- BSII N/A
- Industry
- CRGX
- BSII
- Sector
- CRGX
- BSII
- Exchange
- CRGX Nasdaq
- BSII Nasdaq
- Market Cap
- CRGX 180.4M
- BSII 192.2M
- IPO Year
- CRGX 2023
- BSII 2024
- Fundamental
- Price
- CRGX $4.12
- BSII $10.00
- Analyst Decision
- CRGX Hold
- BSII
- Analyst Count
- CRGX 7
- BSII 0
- Target Price
- CRGX $4.67
- BSII N/A
- AVG Volume (30 Days)
- CRGX 788.2K
- BSII 4.8K
- Earning Date
- CRGX 05-13-2025
- BSII 01-01-0001
- Dividend Yield
- CRGX N/A
- BSII N/A
- EPS Growth
- CRGX N/A
- BSII N/A
- EPS
- CRGX N/A
- BSII N/A
- Revenue
- CRGX N/A
- BSII N/A
- Revenue This Year
- CRGX $64.32
- BSII N/A
- Revenue Next Year
- CRGX N/A
- BSII N/A
- P/E Ratio
- CRGX N/A
- BSII $104.62
- Revenue Growth
- CRGX N/A
- BSII N/A
- 52 Week Low
- CRGX $3.00
- BSII $9.85
- 52 Week High
- CRGX $25.45
- BSII $10.35
- Technical
- Relative Strength Index (RSI)
- CRGX 41.82
- BSII N/A
- Support Level
- CRGX $3.98
- BSII N/A
- Resistance Level
- CRGX $4.25
- BSII N/A
- Average True Range (ATR)
- CRGX 0.21
- BSII 0.00
- MACD
- CRGX 0.14
- BSII 0.00
- Stochastic Oscillator
- CRGX 43.42
- BSII 0.00
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About BSII Black Spade Acquisition II Co Class A Ordinary Share
Black Spade Acquisition II Co is a blank check company.